Equities

Premier Health of America Inc

PHA:CVE

Premier Health of America Inc

Actions
  • Price (CAD)0.14
  • Today's Change0.005 / 3.70%
  • Shares traded19.00k
  • 1 Year change-62.67%
  • Beta0.6031
Data delayed at least 15 minutes, as of Sep 20 2024 19:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Premier Health of America Inc had net income fall 1,427.22% from a loss of 111.51k to a larger loss of 1.70m despite revenues that grew 12.28% from 80.51m to 90.39m over the same period.
Gross margin19.31%
Net profit margin-8.20%
Operating margin-4.14%
Return on assets-17.73%
Return on equity-98.38%
Return on investment-22.77%
More ▼

Balance sheet in CADView more

Premier Health of America Inc has a Debt to Total Capital ratio of 89.12%, a lower figure than the previous year's 138.40%.
Current ratio1.91
Quick ratio--
Total debt/total equity8.19
Total debt/total capital0.8912
More ▼

Growth rates in CAD

Year on year, growth in earnings per share excluding extraordinary items dropped -1,414.85%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-6,389.37
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.